As the authors could not indicate the significance of mutated SATB1 and its expression in high-grade nodal lymphomas in dogs, further study is required to confirm the significant pathogenesis, and a target drug that could restore SATB1 function might be helpful for the treatment of canine lymphomas. The gene discussed is SATB1; the disease is lymphoma.